About Us

  • Home
  • ABOUT US
    • ABOUT US
    • DOMESTIC PRODUCTS
    • IMPORTED PRODUCTS
    • PR
    • CUSTOMER SUPPORT
  • About Us
    • About Us
    • History
    • Achievements
    • Locations

MAKING SURGICAL HISTORY

MEDITULIP focuses on clinical differentiation in minimally invasive surgery
and suggests a new paradigm of cancer treatment

Since its establishment in April 2015, MEDITULIP Co., Ltd. has made remarkable achievements. Within a year since its establishment, it was selected for the TIPS Program for the first time as a national university (September 2015), certified as a venture firm, registered four domestic patents, five international patents and filed six international applications as well as two PCT applications for our stapler. We also registered 1 domestic patent and filed 1 PCT for our chemoport.

Moreover, we have obtained a factory site within the Osong Bio-Health Science Technopolis and start to manufacture products from 2018.

Furthermore, we established MEDITULIP Global, Inc., a sales and market access company as a subsidiary, to expedite the distribution of MEDITULIP products domestically and overseas and to import innovative products from abroad. 

We will continue to make a second and a third "Surgical History" through continuous research and development based on our clinical focus and development skills. MEDITULIP Co., Ltd. promises to serve as the light and the salt of the world, contributing to the human welfare through continuous innovation, services, and donations.  

CEO

Min-Woong Kang

MD/PhD, CEO of MEDITULIP Co., Ltd.
Associate Professor, Chief of Thoracic Division, Department of Thoracic and Cardiovascular Surgery, Chungnam National University.

Professional Experience
  • National Institute of Medical Device Safety Information (NIDS): Advisor for medical device problems
  • KFDA: Advisory panel member of Medical device
  • Deputy of Director, Korean Society of Thoracic and Cardiovascular Surgery
  • Faculty member of ATCCS 2018, Hong Kong
  • Faculty member of ATSOP 2017, Singapore
  • Faculty member of 2nd Asian single port VATS surgery symposium
  • Member of The Korean Society for Thoracic and Cardiovascular Surgery
  • Member of The Korean Association for Lung Cancer Society
  • Member of The Korean society for Thoracic Surgical Oncology
  • Member of International Association for the Study of Lung Cancer
  • Member of Korean Association for the Study of Lung Cancer
  • Editorial Board member of Korean Association for the Study of Lung Cancer (Journal of Lung Cancer)
  • Scientific committee member of The Korean Society for Thoracic and Cardiovascular Surgery
  • Scientific committee member of The Korean Society for Thoracic Oncologic Surgery
Education
  • 2010 : Johnson and Johnson Medical award
  • 2009 : Scientific award of Korean Society for Thoracic and Cardiovascular Surgery.
Seungwan Sohn

CEO of MEDITULIP Global, Inc.

Professional Experience
  • Country Manager at Intuitive Surgical  Korea
  • Head of Strategic Planning and Head of Marketing at Samsung Medison
  • Marketing Director at Stryker  Korea
  • Senior Consultant at IBM GBS
  • Vice President at Nemo Partners
Education
  • BS degree in chemistry and MS in biochemistry from Seoul National University
  • MBA from Kellogg School of Management